Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-11 | New | $100,000 | $100,000 | Equity Only | 06b | SEC link |
| 2023-12-01 | New | $2,000,000 | $2,000,000 | Debt Only | 06b | SEC link |
| 2023-04-05 | Amended | $992,600 | $587,600 | Debt Only | 06b | SEC link |
| 2023-01-23 | New | $405,000 | $405,000 | Debt Only | 06b | SEC link |
| 2021-10-20 | New | $3,000,000 | $3,000,000 | Debt Only | 06b | SEC link |
| 2020-10-08 | Amended | $1,000,000 | $500,000 | Equity Only | 06b | SEC link |
| 2020-01-23 | New | $500,000 | $500,000 | Equity Only | 06b | SEC link |
| 2010-09-30 | New | $30,000 | $30,000 | Equity Only | 06 | SEC link |
| 2010-01-06 | New | $87,500 | $87,500 | Equity Only | 06 | SEC link |
| 2008-02-14 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| John Evans | Director |
| Christopher Furman | Director, Executive |
| Chris Furman | Director, Executive |
| Nathan Haas | Executive |
| Caroline Mosessian | Director |
| James Musick | Director |
| Thomas Ohrt | Executive |
| John Packs | Director |
| Tiana States | Executive |
| Erik Van Horn | Director |
| Jack Zamora | Director, Executive |